[Experimental therapy of rheumatoid arthritis with antibodies to tumor necrosis factor].
Manger
B
B
Institut für klinische Immunologie und Rheumatologie, Friedrich-Alexander-Universität Erlangen-Nürnberg.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000502:physiology
D000911:Antibodies, Monoclonal; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha
Experimentelle Therapie der rheumatoiden Arthritis mit Antikörpern gegen Tumor-Nekrose-Faktor.